- $326.82m
- $246.26m
- $493.69m
- 41
- 94
- 63
- 73
Annual income statement for Xperi, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 376 | 486 | 502 | 521 | 494 |
| Cost of Revenue | |||||
| Gross Profit | 298 | 361 | 379 | 403 | 380 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 529 | 648 | 1,252 | 651 | 480 |
| Operating Profit | -153 | -162 | -749 | -130 | 13.8 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -151 | -160 | -748 | -130 | 11.6 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -141 | -179 | -761 | -140 | -0.869 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -138 | -176 | -757 | -137 | -14 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -138 | -176 | -757 | -137 | -14 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -3.32 | -4.21 | -8.44 | -3.15 | -1.74 |